These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists. Falko JM Endocr Pract; 2018 Aug; 24(8):756-763. PubMed ID: 30183397 [TBL] [Abstract][Full Text] [Related]
4. Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia. Paragh G; Németh Á; Harangi M; Banach M; Fülöp P Lipids Health Dis; 2022 Feb; 21(1):21. PubMed ID: 35144640 [TBL] [Abstract][Full Text] [Related]
5. Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations. Vigna GB; Citroni N; Tarugi P; Fellin R J Clin Lipidol; 2022; 16(5):591-595. PubMed ID: 35945124 [TBL] [Abstract][Full Text] [Related]
6. Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study. Rodriguez FH; Estrada JM; Quintero HMA; Nogueira JP; Porras-Hurtado GL Lipids Health Dis; 2023 Mar; 22(1):43. PubMed ID: 36978188 [TBL] [Abstract][Full Text] [Related]
7. Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report. Lin MH; Tian XH; Hao XL; Fei H; Yin JL; Yan DD; Li T BMC Pregnancy Childbirth; 2020 May; 20(1):272. PubMed ID: 32375710 [TBL] [Abstract][Full Text] [Related]
8. Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion. Santos RD; Lorenzatti A; Corral P; Nogueira JP; Cafferata AM; Aimone D; Lourenço CM; Izar MC; Lima JG; Lottenberg AM; Alonso R; Garay K; Morales AR; Vargas-Uricoechea H; Peña CAC; Roman-González A J Clin Lipidol; 2021; 15(5):620-624. PubMed ID: 34920815 [TBL] [Abstract][Full Text] [Related]
9. A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome. Paquette M; Hegele RA; Paré G; Baass A J Clin Lipidol; 2018; 12(2):506-510. PubMed ID: 29452893 [TBL] [Abstract][Full Text] [Related]
10. Building a better understanding of the burden of disease in familial chylomicronemia syndrome. Ahmad Z; Halter R; Stevenson M Expert Rev Clin Pharmacol; 2017 Jan; 10(1):1-3. PubMed ID: 27771961 [No Abstract] [Full Text] [Related]
11. Molecular and functional characterization of familial chylomicronemia syndrome. Teramoto R; Tada H; Kawashiri MA; Nohara A; Nakahashi T; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K Atherosclerosis; 2018 Feb; 269():272-278. PubMed ID: 29153744 [TBL] [Abstract][Full Text] [Related]
12. Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome. Paquette M; Amyot J; Fantino M; Baass A; Bernard S J Clin Endocrinol Metab; 2021 Aug; 106(9):e3473-e3482. PubMed ID: 34019660 [TBL] [Abstract][Full Text] [Related]
13. Familial chylomicronemia in a nine months old infant. Lone SW; Imdad A; Billoo AG J Coll Physicians Surg Pak; 2008 Oct; 18(10):655-6. PubMed ID: 18940129 [TBL] [Abstract][Full Text] [Related]
14. Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management. Brown WV; Goldberg I; Duell B; Gaudet D J Clin Lipidol; 2018; 12(2):254-263. PubMed ID: 29534878 [TBL] [Abstract][Full Text] [Related]